Trade TNGX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Tango Therapeutics, Inc. (TNGX) is trading at US$21.75, down 7.41% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$4.03B. Over the past 52 weeks, TNGX has traded between US$6.69 and US$34.39. On Syfe you can trade TNGX with $0 commission and add it to your watchlist.
| Previous close | US$23.49 |
|---|---|
| Market cap | US$4.03B |
| 52-week range | US$6.69 – US$34.39 |
| Volume | 6.24M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Tango Therapeutics, Inc.
Tango Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in discovering and delivering precision cancer medicines. It also identifies novel targets and develops new drugs directed at tumor suppressor gene loss in defined patient populations with high unmet medical need. The company was founded by Alan Ashworth, William G. Kaelin Jr., Jose Baselga, Antoni Ribas and Barbara Weber in 2017 and is headquartered in Boston, MA.
Year: 2021
Tango Therapeutics Q2 Net Loss Widens
Aug 11, 11:40 AM · MT Newswires
--Earnings Flash (TNGX) Tango Therapeutics Posts Q2 Loss $0.37 a Share, vs. FactSet Est of $0.32 Loss
Aug 11, 11:03 AM · MT Newswires
Tango Therapeutics Executive Chair Barbara Weber Departs
Aug 7, 6:37 PM · MT Newswires
Mizuho Raises Price Target on Tango Therapeutics to $40 From $36, Keeps Outperform Rating
Jul 17, 10:52 AM · MT Newswires
Tango Therapeutics, Inc. (TNGX) stock is trading at US$21.75, -7.41% from the previous close of US$23.49.
The market cap for Tango Therapeutics, Inc. (TNGX) stock is approximately US$4.03B.
The 52-week high for Tango Therapeutics, Inc. (TNGX) stock is US$34.39.
The 52-week low for Tango Therapeutics, Inc. (TNGX) stock is US$6.69.
Tango Therapeutics, Inc. (TNGX) does not currently pay a dividend.
Stay on top of TNGX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
